The EP300/TP53 pathway, a suppressor of the Hippo and canonical WNT pathways, is activated in human hearts with arrhythmogenic cardiomyopathy in the absence of overt heart failure.

Fecha de publicación: Fecha Ahead of Print:

Autores de IIS La Fe

Participantes ajenos a IIS La Fe

  • Rouhi L
  • Fan S
  • Cheedipudi SM
  • Molina MS
  • Yao Y
  • Robertson MJ
  • Coarfa C
  • Gimeno JR
  • Molina P
  • Gurha P
  • Marian AJ

Grupos

Abstract

Arrhythmogenic cardiomyopathy (ACM) is a primary myocardial disease that typically manifests with cardiac arrhythmias, progressive heart failure and sudden cardiac death (SCD). ACM is mainly caused by mutations in genes encoding desmosome proteins. Desmosomes are cell-cell adhesion structures and hubs for mechanosensing and mechanotransduction. The objective was to identify the dysregulated molecular and biological pathways in human ACM in the absence of overt heart failure.

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2021. For permissions, please email: journals.permissions@oup.com.

Datos de la publicación

ISSN/ISSNe:
0008-6363, 1755-3245

CARDIOVASCULAR RESEARCH  OXFORD UNIV PRESS

Tipo:
Article
Páginas:
1466-1478
PubMed:
34132777
Factor de Impacto:
2,711 SCImago
Cuartil:
Q1 SCImago

Citas Recibidas en Web of Science: 35

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • Cardiomyopathy, Gene expression, Hippo pathway, RNA-Sequencing, TP53, WNT pathway

Campos de Estudio

Cita

Compartir